Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma
- PMID: 1559227
Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma
Abstract
The p53 gene was examined in primary or metastatic tumors from six patients with rhabdomyosarcoma (RMS) and in five RMS cell lines by screening methods including single-strand conformation polymorphism analysis, the RNase protection assay, sequencing of complementary DNA subclones, and Southern blotting. Six original tumors were of embryonal histology, four alveolar, and one mixed. p53 mutations were identified in four of the six tumors or cell lines derived from tumors with embryonal histology and in one of the four with alveolar histology. Consistent with p53 allele loss, each mutation was found in the homo- or hemizygous state. One tumor showed a G to C transversion at p53 codon 213 (arginine to proline), and another showed deletion of the entire gene. The p53 mutations in cell lines included a codon 248 C to T transition (arginine to tryptophan) in RD and a codon 280 A to T transversion (arginine to serine) in RH30. The cell line CTR contained a 4-base pair deletion at codons 219/220 in exon 6 with resultant frame shift and premature termination in exon 7. These data support the role of diverse types of p53 mutations in the pathogenesis and/or progression of a significant proportion of cases of childhood RMS.
Similar articles
-
Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia.J Clin Invest. 1992 Feb;89(2):640-7. doi: 10.1172/JCI115630. J Clin Invest. 1992. PMID: 1737852 Free PMC article.
-
Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 1):297-302. Cancer Epidemiol Biomarkers Prev. 1999. PMID: 10207632
-
Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas.Cancer Res. 1993 Nov 1;53(21):5284-8. Cancer Res. 1993. PMID: 8221663
-
p53 gene mutation spectrum in human unknown primary tumors.Anticancer Res. 1993 Sep-Oct;13(5A):1619-23. Anticancer Res. 1993. PMID: 8239543
-
A unique spectrum of p53 mutations in B-cell chronic lymphocytic leukemia distinct from that of other lymphoid malignancies.Mol Carcinog. 1995 Dec;14(4):227-32. doi: 10.1002/mc.2940140402. Mol Carcinog. 1995. PMID: 8519411 Review.
Cited by
-
DUX4-induced dsRNA and MYC mRNA stabilization activate apoptotic pathways in human cell models of facioscapulohumeral dystrophy.PLoS Genet. 2017 Mar 8;13(3):e1006658. doi: 10.1371/journal.pgen.1006658. eCollection 2017 Mar. PLoS Genet. 2017. PMID: 28273136 Free PMC article.
-
Circ-ZNF609 regulates G1-S progression in rhabdomyosarcoma.Oncogene. 2019 May;38(20):3843-3854. doi: 10.1038/s41388-019-0699-4. Epub 2019 Jan 22. Oncogene. 2019. PMID: 30670781 Free PMC article.
-
Activating Death Receptor DR5 as a Therapeutic Strategy for Rhabdomyosarcoma.ISRN Oncol. 2012;2012:395952. doi: 10.5402/2012/395952. Epub 2012 Apr 17. ISRN Oncol. 2012. PMID: 22577581 Free PMC article.
-
Cytomegalovirus infection leads to pleomorphic rhabdomyosarcomas in Trp53+/- mice.Cancer Res. 2012 Nov 15;72(22):5669-74. doi: 10.1158/0008-5472.CAN-12-2425. Epub 2012 Sep 21. Cancer Res. 2012. PMID: 23002204 Free PMC article.
-
DNA damage, somatic aneuploidy, and malignant sarcoma susceptibility in muscular dystrophies.PLoS Genet. 2011 Apr;7(4):e1002042. doi: 10.1371/journal.pgen.1002042. Epub 2011 Apr 14. PLoS Genet. 2011. PMID: 21533183 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous